ISCNF News and Press, Isracann Biosciences From 04/15/22

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that further to its acquisition of Praesidio Health Inc. as a natural health medicine division, th...

Isracann Biosciences (OTCPK:ISCNF) has closed its acquisition of Praesidio Health by acquiring all of the issued and outstanding shares in the capital of Praesidio for aggregate consideration of C$4M, in common shares in the capital of the Co. Praesidio will operate as a wholly-owned subsidia...

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it...

Isracann Biosciences (OTCPK:ISCNF) will acquire all shares in the capital of Praesidio for aggregate consideration of C$4M in common shares of the company. Praesidio Health is an industry-leading, Canadian medical research company that develops and validates natural health medicine ...

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a ...

Nick Gastevich, one of our favorite commenters on Seeking Alpha, returns to the show to catch us up on the state of cannabis investing. Wave of new states legalizing cannabis now especially important in the face of long federal delays. Liking GTI but it's historically had slightly...

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on researching and developing innovative health solutions in conjunct...

Isracann Biosciences (OTCPK:ISCNF) to acquire Praesidio Health of Canada. The appointment of Mr. Phil Floucault to the position of company’s CEO in late October of 2021, allowed for a period of investigation, reflection and ultimately offered an opportunity for Mr. ...

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on researching and developing innovative health solutions in conjuncti...

Isracann Biosciences (OTCPK:ISCNF) has appointment of Phil Floucault to the position of CEO in late Oct. has provided a 2–3-month window of opportunity for perspective and understanding of virtually every aspect of the operational preparedness of the Co. and stakeholders. The...